Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Sales $ 0 $ 0 $ 0 $ 0
Operating expenses:        
General and administrative 394,654 306,834 1,131,662 944,571
Research and development 0 101,500 79,550 101,500
Facility operations 154,470 41,375 234,113 180,934
Depreciation and amortization 18,173 15,958 37,850 41,521
Total operating expenses 567,297 465,667 1,483,175 1,268,526
Net loss from operations (567,297) (465,667) (1,483,175) (1,268,526)
Other income (expense):        
Interest expense (42,541) (40,820) (102,057) (160,351)
Amortization of debt discount 0 (38,831) 0 (515,204)
Financing costs 0 (53,528) (64,452) (217,746)
Change in fair value of derivative liability 0 58,000 (29,000) 19,000
Change in fair value of warrant liability 0 0 0 0
Loss on warrant settlement 0 0 0 (50,000)
Total other income (expense) (42,541) (75,179) (195,509) (924,301)
Loss before income taxes (609,838) (540,846) (1,678,684) (2,192,827)
Provision for income taxes 0 0 0 0
Net loss (609,838) (540,846) (1,678,684) (2,192,827)
Less net loss attributable to non-controlling interest (1,074) (51,363) (4,655) (51,363)
Net loss attributable to Natural Shrimp Inc. (608,764) (489,483) (1,674,029) (2,141,464)
Amortization of beneficial conversion feature on Series B PS (443,333) (380,000) (1,543,333) (380,000)
Dividends (172,291) 0 (317,083) 0
Net loss available for common stockholders $ (1,224,388) $ (869,483) $ (3,534,445) $ (2,521,464)
Earnings per share (basic and diluted) $ (0.00) $ (0.00) $ (0.01) $ (0.01)
Weighted average share outstanding (basic and diluted) 451,549,772 345,260,292 419,177,832 326,835,226